Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's

FromThe Lancet Neurology in conversation with

Start listening View podcast show

Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's

FromThe Lancet Neurology in conversation with

ratings:

Length:

27 minutes

Released:

Apr 6, 2022

Format:

Podcast episode

Description

Estrella Morenas-Rodriguez and Christian Haass (German Centre for Neurodegenerative Diseases, Munich, Germany) discuss their recent research, published in the April issue of The Lancet Neurology, on soluble TREM2 and its association with Alzheimer’s disease biomarkers and cognition.

Released:

Apr 6, 2022

Format:

Podcast episode

Titles in the series (100)

Our Editors and and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.

Skip carousel

The Lancet Neurology: December 08, 2008 by The Lancet Neurology in conversation with
9 min listen
The Lancet Neurology: March 16, 2009 by The Lancet Neurology in conversation with
9 min listen
The Lancet Neurology: July 14, 2008 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: March 14, 2008 by The Lancet Neurology in conversation with
5 min listen
The Lancet Neurology: December 17, 2007 by The Lancet Neurology in conversation with
7 min listen
The Lancet Neurology: January 22, 2008 by The Lancet Neurology in conversation with
5 min listen
The Lancet Neurology: June 16, 2008 by The Lancet Neurology in conversation with
16 min listen
The Lancet Neurology: October 12, 2009 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: October 13, 2008 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: February 18, 2008 by The Lancet Neurology in conversation with
5 min listen
The Lancet Neurology: August 11, 2008 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: November 10, 2008 by The Lancet Neurology in conversation with
6 min listen
The Lancet Neurology: April 18, 2008 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: September 20, 2010 by The Lancet Neurology in conversation with
10 min listen
The Lancet Neurology: February 21, 2011 by The Lancet Neurology in conversation with
10 min listen
The Lancet Neurology: September 15, 2008 by The Lancet Neurology in conversation with
7 min listen
The Lancet Neurology: December 14, 2009 by The Lancet Neurology in conversation with
13 min listen
The Lancet Neurology: August 15, 2011 by The Lancet Neurology in conversation with
15 min listen
The Lancet Neurology: June 15, 2009 by The Lancet Neurology in conversation with
6 min listen
The Lancet Neurology: May 19, 2008 by The Lancet Neurology in conversation with
7 min listen
The Lancet Neurology: January 19, 2009 by The Lancet Neurology in conversation with
10 min listen
The Lancet Neurology: June 17, 2010 by The Lancet Neurology in conversation with
9 min listen
The Lancet Neurology: August 16, 2010 by The Lancet Neurology in conversation with
8 min listen
The Lancet Neurology: December 13, 2010 by The Lancet Neurology in conversation with
6 min listen
The Lancet Neurology: January 19, 2011 by The Lancet Neurology in conversation with
9 min listen
The Lancet Neurology: August 19, 2009 by The Lancet Neurology in conversation with
10 min listen
The Lancet Neurology: July 13, 2012 by The Lancet Neurology in conversation with
11 min listen
The Lancet Neurology: September 08, 2009 by The Lancet Neurology in conversation with
7 min listen
The Lancet Neurology: May 19, 2010 by The Lancet Neurology in conversation with
9 min listen
The Lancet Neurology: April 15, 2009 by The Lancet Neurology in conversation with
7 min listen

More Episodes from The Lancet Neurology in conversation with

Skip carousel

Jacqueline French and Jacob Pellinen on the diagnosis of epilepsy by The Lancet Neurology in conversation with
23 min listen
Jaimie Steinmetz, Theo Vos, Katrin Seeher and Tarun Dua on the global burden of disorders affecting the nervous system by The Lancet Neurology in conversation with
25 min listen
Giovanni Frisoni on biomarker-based diagnosis of neurocognitive disorders by The Lancet Neurology in conversation with
12 min listen
Marianne Chapleau and Gil Rabinovici on posterior cortical atrophy by The Lancet Neurology in conversation with
22 min listen
Cecilia Åkerlund and David Nelson on prognosis of traumatic brain injury by The Lancet Neurology in conversation with
18 min listen
Rustam Al-Shahi Salman on the effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage by The Lancet Neurology in conversation with
24 min listen
Njideka Okubadejo and Mie Rizig on Parkinson's disease in African and African admixed populations by The Lancet Neurology in conversation with
27 min listen
Anthony Feinstein on a trial of cognitive rehabilitation and exercise in people with progressive multiple sclerosis by The Lancet Neurology in conversation with
15 min listen
William Jagust on amyloid β and cognition by The Lancet Neurology in conversation with
14 min listen
Stephen Strittmatter on a first-in-human trial for treating chronic cervical spinal cord injury by The Lancet Neurology in conversation with
15 min listen
Benzi Kluger, Claire Creutzfeldt, and Malenna Sumrall on palliative care for individuals with neurological diseases by The Lancet Neurology in conversation with
17 min listen
Andrew Cole on the complexities underlying epilepsy in people with glioblastoma by The Lancet Neurology in conversation with
19 min listen
Karen Duff and Connor Langworth-Green on tauopathies and chronic inflammation by The Lancet Neurology in conversation with
15 min listen
Kerstin Hellwig on family planning considerations in MS by The Lancet Neurology in conversation with
14 min listen
Geraldine Dawson on advances and in the prediction of autism during infancy by The Lancet Neurology in conversation with
25 min listen
Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke by The Lancet Neurology in conversation with
9 min listen
Beau Ances on amyloid biomarkers in Alzheimer’s by The Lancet Neurology in conversation with
12 min listen
Axel Petzold on the diagnosis and classification of optic neuritis by The Lancet Neurology in conversation with
20 min listen
Maeike Zijlmans on using biomarkers to tailor epilepsy surgery by The Lancet Neurology in conversation with
15 min listen
Jerome Siegel on sleep habits by The Lancet Neurology in conversation with
44 min listen
Laurent Servais and Dora Markati on emerging therapies for Duchenne muscular dystrophy by The Lancet Neurology in conversation with
17 min listen
Andreas Charidimou on new criteria for diagnosis of cerebral amyloid angiopathy by The Lancet Neurology in conversation with
23 min listen
Sarah Tabrizi and Cristina Sampaio on classifying Huntington's and new therapies by The Lancet Neurology in conversation with
19 min listen
Mark Hallett on functional neurological disorder by The Lancet Neurology in conversation with
9 min listen
Eva Feldman on advances in understanding ALS by The Lancet Neurology in conversation with
23 min listen
John Collinge on a treatment for CJD by The Lancet Neurology in conversation with
15 min listen
Alexandra Durr on riluzole in patients with spinocerebellar ataxia type 2 by The Lancet Neurology in conversation with
8 min listen
Giuseppe Citerio on frailty and TBI by The Lancet Neurology in conversation with
10 min listen
Alberto Costa on memantine in adolescents and young adults with Down syndrome by The Lancet Neurology in conversation with
15 min listen
Olivier Rascol on amantadine for patients with movement disorders by The Lancet Neurology in conversation with
28 min listen

Related podcast episodes

Skip carousel

Menand on Psychiatry: Louis Menand talks with host Russ Roberts about the state of psychiatry. Drawing on his recent article in the New Yorker, he talks about the scientific basis for making conclusions about mental illness and various therapies. He argues that the research record shows little difference between the effectiveness of psychopharmacology and talk therapies of various kinds in fighting depression. Neither is particularly successful in any one case. Other topics that are discussed include the parallels between economics and psychiatry in assessing causation, the diminished role of Freudianism in modern psychiatry, and the range of issues involved in using medication to avoid pain and hardship. by EconTalk Archives, 2010
59 min listen
Menand on Psychiatry: Louis Menand talks with host Russ Roberts about the state of psychiatry. Drawing on his recent article in the New Yorker, he talks about the scientific basis for making conclusions about mental illness and various therapies. He argues that the research record shows little difference between the effectiveness of psychopharmacology and talk therapies of various kinds in fighting depression. Neither is particularly successful in any one case. Other topics that are discussed include the parallels between economics and psychiatry in assessing causation, the diminished role of Freudianism in modern psychiatry, and the range of issues involved in using medication to avoid pain and hardship. by EconTalk
59 min listen
Could We Cure Mental Illness? The MDMA Story: Could a cure be on the way for mental illness? In today’s episode we’re talking with two leading minds in the psychedelic therapy space, Dr. Rick Doblin PhD and Dr. Ben Sessa MD, working on MDMA-assisted therapy, the most promising breakthrough... by Your Brain Explained
64 min listen
Mark Hallett on functional neurological disorder by The Lancet Neurology in conversation with
9 min listen
ACC CardiaCast: Understanding AL and ATTR Cardiac Amyloidosis by ACC CardiaCast
18 min listen
Molecular Mechanisms of Depression with Dr. Lisa Monteggia: On this episode of Brian Matters, Anthony and Dr. Lisa Monteggia (Professor, UT Southwestern Medical Center) talked about depression and the molecular mechanisms underlying the efficacy of antidepressants. They also talked about Lisa's work... by Brain Matters
41 min listen
Patient Care at the Intersection of Rheumatology and Neurology: Rheumatologists and neurologists are known to manage and collaborate between their specialties in the care of patients with shared diagnoses, such as disorders of the central nervous system, like giant cell arthritis and neuropsychiatric lupus. In... by Rheum Advisor on Air
22 min listen
HOT TOPICS: Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors: This week's Hot Topic is Intravenous Levothyroxine for Unstable Brain-Dead Heart Donors and Dr Nicholas Morris is joined by Dr Raj Dhar from Washington University School of Medicine to discuss his latest New England Journal of Medicine manuscript (. by Neurocritical Care Society Podcast
55 min listen
Fear Conditioning (with Mohammed Milad, PhD) by NYU Langone Insights on Psychiatry
42 min listen
#108: Charles Raison & Vladimir Maletic, Tackling Depression with a Mind-Body Approach: Chuck Raison, a psychiatrist and a professor of psychiatry at the University of Wisconsin-Madison School of Medicine and Public Health, and Vlad Maletic, a clinical professor of neuropsychiatry and behavior science at the University of South Carolina School of Medicine, wrote a book together called, "The New Mind-Body Science of Depression," in which they offer research on the mind-body connection, such as looking at the immune system, as a way to tackle depression. But their conversation also delves into the Tibetan Buddhist tradition of tummo, psychedelics and "dark" retreats. by Ten Percent Happier with Dan Harris
64 min listen
Vincenzo Di Nicola - The Crisis in Psychiatry and The Slow Way Back: Mad in America: Rethinking Mental Health by Mad in America: Rethinking Mental Health
51 min listen
August 28 2012 Issue: Reportable neurologic disorders in refugee camps in 19 countries: A retrospective study by Neurology® Podcast
24 min listen
Delayed Recall - Cognitive Impairment (March 2018): Delayed Recall - Cognitive Impairment (March 2018) by Neurology® Podcast
27 min listen
Linda L. Michaels et al.. "Advancing Psychotherapy for the Next Generation: Humanizing Mental Health Policy and Practice" (Routledge, 2023): An interview with Linda L. Michaels by New Books in Psychology
52 min listen
Linda L. Michaels et al.. "Advancing Psychotherapy for the Next Generation: Humanizing Mental Health Policy and Practice" (Routledge, 2023): An interview with Linda L. Michaels by New Books in Public Policy
52 min listen
Linda L. Michaels et al.. "Advancing Psychotherapy for the Next Generation: Humanizing Mental Health Policy and Practice" (Routledge, 2023): An interview with Linda L. Michaels by New Books in Psychoanalysis
52 min listen
Supervisor Cultural Humility and Supervisee Nondisclosure: The Supervisory Working Alliance Matters: In this episode of The Counseling Psychologist podcast series, Drs. Melissa Ertl and Michael Ellis talk about their article recently published in TCP titled, "Supervisor Cultural Humility and Supervisee Nondisclosure: The Supervisory Working Alliance... by SAGE Psychology & Psychiatry
32 min listen
Episode 1: Neuroscience of Anxiety by Neuroscience: Amateur Hour
21 min listen
June 3 2014 Issue: Anti-agrin autoantibodies in myasthenia gravis by Neurology® Podcast
24 min listen
Esketamine: A Drug to Treat Resistant Depression That Brings More Questions Than Answers: Authors Nicholas A. Mischel and Richard Balon discuss their commentary, “Esketamine: A Drug to Treat Resistant Depression That Brings More Questions Than Answers.” Their commentary asks: How does this treatment fit into the broader repertoire in... by The Journal of Clinical Psychopharmacology Podcast
8 min listen
August 7 2012 Issue: A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease by Neurology® Podcast
35 min listen
Psychedelics in the Treatment of Depression: A Critical Appraisal of Evidence: Psychedelics as a potential treatment for depression is an irresistible topic in the mainstream press, but what is the evidence base for their use? In this podcast, psychiatrist and journal Digital Editor Dr. Julia Ann Koretski (of Mass General... by The Journal of Clinical Psychopharmacology Podcast
24 min listen
Christopher M. Palmer, "Brain Energy: A Revolutionary Breakthrough in Understanding Mental Health" (Benbella Books, 2022): An interview with Christopher M. Palmer by New Books in Science
56 min listen
#638 Do you feel love? What about ecstasy?: If you're plugged in to science news (and you, our listeners, definitely are) then you know that psychedelics like ketamine and LSD are having a moment in therapy. But what about Ecstasy (MDMA)? What makes it different, and what could it do? This week ... by Science for the People
60 min listen
Christopher M. Palmer, "Brain Energy: A Revolutionary Breakthrough in Understanding Mental Health" (Benbella Books, 2022): An interview with Christopher M. Palmer by New Books in Psychology
56 min listen
Frank Summers, “The Psychoanalytic Vision” (Routledge, 2013): In The Psychoanalytic Vision: The Experiencing Subject, Transcendence, and the Therapeutic Process (Routledge, 2013), Frank Summers has written a wholly original work of theory, technique and cultural critique. by New Books in Psychoanalysis
62 min listen
January 12 2016 Issue: Neurology® Clinical Practice article titled: Anti-GAD antibody syndrome with concomitant cerebellar ataxia, stiff-person syndrome, and limbic encephalitis by Neurology® Podcast
20 min listen
Trabectedin for recurrent grade 2 or 3 meningiomas: Dr. Iyad Alnahhas interviews Dr. Matthias Preusser about the recent manuscript entitled: "Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)", published online in... by Neuro-Oncology: The Podcast
17 min listen
053 Special Guest: Michele DeMarco by Relationship Revival with Dr. Jon Dabach
43 min listen
Ep. 11: A primer to Multiple Sclerosis: Moderator: Prof. Christian Enzinger (Graz, Austria) Guest: Prof. Andrew Chan (Bern, Switzerland) Prof. Christian Enzinger, co-chair of the EAN Scientific Panel on Multiple Sclerosis, moderates the first of this month’s episodes alongside specialist Prof. Andrew Chan. The two discuss the basic understanding of the epidemiology, neuroimmunology and clinical characteristics of MS. by eanCast: Weekly Neurology
21 min listen

Discover this podcast and so much more

Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's

Estrella Morenas-Rodriguez and Christian Haass on soluble TREM2 and Alzheimer's

Description

Titles in the series (100)

More Episodes from The Lancet Neurology in conversation with

Related podcast episodes